Aardvark Therapeutics, Inc.
AARD
$5.39
$0.020.37%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 13.79M | 10.77M | 7.83M | 7.17M | 5.42M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 62.73M | 53.47M | 40.86M | 31.08M | 22.79M |
| Operating Income | -62.73M | -53.47M | -40.86M | -31.08M | -22.79M |
| Income Before Tax | -57.59M | -48.77M | -36.64M | -27.72M | -20.59M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -57.59 | -48.77 | -36.64 | -27.72 | -20.59 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -57.59M | -48.77M | -36.64M | -27.72M | -20.59M |
| EBIT | -62.73M | -53.47M | -40.86M | -31.08M | -22.79M |
| EBITDA | -62.69M | -53.44M | -40.83M | -31.07M | -22.77M |
| EPS Basic | -2.93 | -4.28 | -4.58 | -5.29 | -5.13 |
| Normalized Basic EPS | -1.83 | -2.67 | -2.84 | -3.29 | -3.17 |
| EPS Diluted | -2.93 | -4.28 | -4.58 | -5.29 | -5.13 |
| Normalized Diluted EPS | -1.83 | -2.67 | -2.84 | -3.29 | -3.17 |
| Average Basic Shares Outstanding | 78.38M | 60.66M | 42.94M | 25.21M | 15.99M |
| Average Diluted Shares Outstanding | 78.38M | 60.66M | 42.94M | 25.21M | 15.99M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |